DCF fair value estimate for Alkermes plc: $58.
Get informed when a big investor buys or sells
+ Follow$57.60
Undervalued by 25.3% based on the discounted cash flow analysis.
Alkermes plc's discounted cash flow stands at $58. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Discounted cash flow values ALKS by forecasting cash the business could generate and bringing those cash flows to present value. Stockcircle's latest estimate is $58, implying the shares look undervalued by about 25.3%. Pair DCF with P/E, growth, and balance-sheet metrics before making a decision.
The history chart shows how Alkermes plc's DCF fair value evolved across reporting periods, while the comparison chart places ALKS next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, DCF fair value is commonly used to spot outliers. Alkermes plc's reading of $58 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.